BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Eric Linsley will co-chair the CED's 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
